PURPOSE OF THE STUDY: To determine whether pioglitazone will improve menstrual cyclicity in a fetal programming model for polycystic ovary syndrome. BASIC PROCEDURES: Eight prenatally androgenized (PA) and 5 control female rhesus monkeys of similar age, body weight and body mass index received an oral placebo daily for 6-7 months followed, after at least 90 days, by daily oral dosing with pioglitazone (3mg/kg) for an additional 6-7 months. Blood was sampled thrice weekly to monitor ovulatory function, and a variety of endocrine challenges were performed to quantify changes in ovarian, gonadotropin and glucoregulatory function. MOST IMPORTANT FINDINGS: Pioglitazone normalized menstrual cycles in 5 out of 8 (62%) PA females (pioglitazone responsive; Pio(RESP)). Pioglitazone increased serum 17alpha-hydroxyprogesterone responses to an hCG injection in Pio(RESP) PA females, while diminishing serum progesterone, and increasing DHEA and estradiol responses to hCG in Pio(RESP) PA and all normal females. PRINCIPAL CONCLUSIONS: Insulin resistance plays a mechanistic role in maintaining anovulation in a majority of PA female monkeys.
PURPOSE OF THE STUDY: To determine whether pioglitazone will improve menstrual cyclicity in a fetal programming model for polycystic ovary syndrome. BASIC PROCEDURES: Eight prenatally androgenized (PA) and 5 control female rhesus monkeys of similar age, body weight and body mass index received an oral placebo daily for 6-7 months followed, after at least 90 days, by daily oral dosing with pioglitazone (3mg/kg) for an additional 6-7 months. Blood was sampled thrice weekly to monitor ovulatory function, and a variety of endocrine challenges were performed to quantify changes in ovarian, gonadotropin and glucoregulatory function. MOST IMPORTANT FINDINGS: Pioglitazone normalized menstrual cycles in 5 out of 8 (62%) PA females (pioglitazone responsive; Pio(RESP)). Pioglitazone increased serum 17alpha-hydroxyprogesterone responses to an hCG injection in Pio(RESP) PA females, while diminishing serum progesterone, and increasing DHEA and estradiol responses to hCG in Pio(RESP) PA and all normal females. PRINCIPAL CONCLUSIONS: Insulin resistance plays a mechanistic role in maintaining anovulation in a majority of PA female monkeys.
Authors: Donna Seto-Young; Maria Paliou; Jonathan Schlosser; Dimiter Avtanski; Alice Park; Parini Patel; Kevin Holcomb; Peter Chang; Leonid Poretsky Journal: J Clin Endocrinol Metab Date: 2005-08-30 Impact factor: 5.958
Authors: Jessica K Wickenheisser; Velen L Nelson-DeGrave; Karen L Hendricks; Richard S Legro; Jerome F Strauss; Jan M McAllister Journal: J Clin Endocrinol Metab Date: 2005-05-24 Impact factor: 5.958
Authors: Mickey S Coffler; Ketan Patel; Michael H Dahan; Richard Y Yoo; Pamela J Malcom; R Jeffrey Chang Journal: J Clin Endocrinol Metab Date: 2003-12 Impact factor: 5.958
Authors: Shweta Sharma; Prem M Sharma; Devendra S Mistry; R Jeffery Chang; Jerrold M Olefsky; Pamela L Mellon; Nicholas J G Webster Journal: Biol Reprod Date: 2010-11-10 Impact factor: 4.285
Authors: David H Abbott; Cristin R Bruns; Deborah K Barnett; Andrea Dunaif; Theodore L Goodfriend; Daniel A Dumesic; Alice F Tarantal Journal: Am J Physiol Endocrinol Metab Date: 2010-08-03 Impact factor: 4.310
Authors: Daniel A Dumesic; Luis R Hoyos; Gregorio D Chazenbalk; Rajanigandha Naik; Vasantha Padmanabhan; David H Abbott Journal: Reproduction Date: 2020-01 Impact factor: 3.906
Authors: David H Abbott; Deborah K Barnett; Jon E Levine; Vasantha Padmanabhan; Daniel A Dumesic; Steve Jacoris; Alice F Tarantal Journal: Biol Reprod Date: 2008-04-02 Impact factor: 4.285
Authors: David H Abbott; Lindsey E Nicol; Jon E Levine; Ning Xu; Mark O Goodarzi; Daniel A Dumesic Journal: Mol Cell Endocrinol Date: 2013-01-29 Impact factor: 4.102